FDA Adverse Event Malfunction Summary report: N

BINAXNOW COVID-19 AG SELF TEST 2CT

MDR report key: 21192988 · Received January 20, 2025

Report

Report Number
1221359-2025-00016
Event Type
Malfunction
Date Received
January 20, 2025
Date of Event
January 1, 2025
Report Date
February 10, 2025
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
Product Code
QKP
PMA / PMN Number
EUA210264
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

B3 - DATE OF EVENT: THE DATE PROVIDED IS AN ESTIMATION AS THE EXACT DATE OF EVENT COULD NOT BE OBTAINED. THE INFORMATION TO ENABLE FURTHER INVESTIGATION, SUCH AS THE KIT'S LOT NUMBER, WAS NOT PROVIDED AND AN INVESTIGATION WAS NOT ABLE TO BE PERFORMED. A PRODUCT DEFICIENCY COULD NOT BE DETERMINED. NOTWITHSTANDING, COMPLAINTS AGAINST THESE TREND CODES ARE MONITORED TO IDENTIFY AND TRACK ANY OUT-OF-TREND/UNEXPECTED PERFORMANCE AT THE LOT AND PRODUCT FAMILY LEVEL.

Additional Manufacturer Narrative · 0

B3 - DATE OF EVENT: THE DATE PROVIDED IS AN ESTIMATION AS THE EXACT DATE OF EVENT COULD NOT BE OBTAINED. CORRECTIONS: A2 - DOB NULL: CHANGED FROM NI TO ASKU TO ALIGN WITH THE COMPLAINT DETAILS. A2 - AGE UNITS (PATIENT): CHANGED FROM NI TO ASKU TO ALIGN WITH THE COMPLAINT DETAILS. A3A - SEX: CHANGED FROM NONE SELECTED TO FEMALE TO ALIGN WITH THE COMPLAINT DETAILS. A3B - GENDER: CHANGED FROM NONE SELECTED TO CISGENDER WOMAN/GIRL (GENDER CORRESPONDS WITH BIRTH SEX) TO ALIGN WITH THE COMPLAINT DETAILS. A4 - WEIGHT UNITS (PATIENT): CHANGED FROM NI TO ASKU TO ALIGN WITH THE COMPLAINT DETAILS. A5 - ETHNICITY: CHANGED FROM NI TO ASKU TO ALIGN WITH THE COMPLAINT DETAILS. A6 - RACE: CHANGED FROM NI TO ASKU TO ALIGN WITH THE COMPLAINT DETAILS. THE INFORMATION TO ENABLE FURTHER INVESTIGATION, SUCH AS THE KIT'S LOT NUMBER, WAS NOT PROVIDED AND AN INVESTIGATION WAS NOT ABLE TO BE PERFORMED. A PRODUCT DEFICIENCY COULD NOT BE DETERMINED. NOTWITHSTANDING, COMPLAINTS AGAINST THESE TREND CODES ARE MONITORED TO IDENTIFY AND TRACK ANY OUT-OF-TREND/UNEXPECTED PERFORMANCE AT THE LOT AND PRODUCT FAMILY LEVEL.

Description of Event or Problem · 0

THE CONSUMER REPORTED FALSE NEGATIVE RESULTS WITH TWO (2) BINAXNOW COVID-19 AG SELF TESTS TAKEN AT AN UNKNOWN DATE. THIS REPORT ADDRESSES TEST ONE (1) OF TWO (2). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH A BINAXNOW COVID-19 AG SELF TEST TAKEN ON AN UNKNOWN DATE. THE CONSUMER MENTIONED A SYMPTOM OF LOSS OF TASTE. NO ADDITIONAL INFORMATION, INCLUDING TREATMENT AND OUTCOME, IS PROVIDED.

Description of Event or Problem · 0

THE CONSUMER REPORTED FALSE NEGATIVE RESULTS WITH TWO (2) BINAXNOW COVID-19 AG SELF TESTS TAKEN AT AN UNKNOWN DATE. THIS REPORT ADDRESSES TEST ONE (1) OF TWO (2). THE CONSUMER REPORTED A FALSE NEGATIVE RESULT WITH A BINAXNOW COVID-19 AG SELF TEST TAKEN ON AN UNKNOWN DATE. THE CONSUMER MENTIONED A SYMPTOM OF LOSS OF TASTE. NO ADDITIONAL INFORMATION, INCLUDING TREATMENT AND OUTCOME, IS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
439646 BINAXNOW COVID-19 AG SELF TEST 2CT CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. QKP ABBOTT DIAGNOSTICS SCARBOROUGH, INC.

Patients

Seq Age Sex Outcome Treatment
1 NA Female